Development of TRAIL resistance by radiation-induced hypermethylation of DR4 CpG Island in recurrent laryngeal squamous cell carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 88, Issue 5, 2014, Pages 1203-1211

  Lee, Jong Cheol ^a   Lee, Won Hyeok ^a   Min, Young Joo ^a   Cha, Hee Jeong ^a   Han, Myung Woul ^a   Chang, Hyo Won ^b   Kim, Sun A ^b   Choi, Seung Ho ^b   Kim, Seong Who ^b   Kim, Sang Yoon ^b,c  

^a University of Ulsan College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Korea Institute of Science and Technology   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE-SEQUENCING; CHEMOTHERAPEUTIC AGENTS; EPIGENETIC SILENCING; LARYNGEAL CARCINOMAS; METHODS AND MATERIALS; RADIATION TREATMENTS; SQUAMOUS CELL CARCINOMA; TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGANDS;

ALKYLATION; CELL CULTURE; CELL DEATH; DISEASES; GENE ENCODING; SURGERY;

RADIOTHERAPY;

GENOMIC DNA; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

AGED; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CPG ISLAND; DNA ISOLATION; DNA METHYLATION; EPIGENETIC REPRESSION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LARYNX SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY; TREATMENT FAILURE; WESTERN BLOTTING;

AGED; APOPTOSIS; AZACITIDINE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CPG ISLANDS; DNA METHYLATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; EPIGENESIS, GENETIC; FEMALE; FLOW CYTOMETRY; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84897888307     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.12.016     Document Type: Article

References (33)

1. A. Argiris, M.V. Karamouzis, and D. Raben et al. Head and neck cancer Lancet 371 2008 1695 1709
2. S.J. Wong, M. Machtay, and Y. Li Locally recurrent, previously irradiated head and neck cancer: Concurrent re-irradiation and chemotherapy, or chemotherapy alone? J Clin Oncol 24 2006 2653 2658
3. J.B. Vermorken, R. Mesia, and F. Rivera et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer N Engl J Med 359 2008 1116 1127
4. R.W. Johnstone, A.J. Frew, and M.J. Smyth The TRAIL apoptotic pathway in cancer onset, progression and therapy Nat Rev Cancer 8 2008 782 798
5. A.M. Chinnaiyan, U. Prasad, and S. Shankar et al. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy Proc Natl Acad Sci U S A 97 2000 1754 1759
6. C.T. Hellwig, and M. Rehm TRAIL signaling and synergy mechanisms used in TRAIL-based combination therapies Mol Cancer Ther 11 2012 3 13
7. O.M. Niemoeller, and C. Belka Radiotherapy and TRAIL for cancer therapy Cancer Lett 332 2013 184 193
8. R.H. Wilting, and J.H. Dannenberg Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance Drug Resist Updat 15 2012 21 38
9. V.F. Chekhun, N.Y. Lukyanova, and O. Kovalchuk et al. Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper- and hypomethylated targets Mol Cancer Ther 6 2007 1089 1098
10. X. Chang, C.L. Monitto, and S. Demokan et al. Identification of hypermethylated genes associated with cisplatin resistance in human cancers Cancer Res 70 2010 2870 2879
11. S.Y. Kim, K.C. Chu, and H.R. Lee et al. Establishment and characterization of nine new head and neck cancer cell lines Acta Otolaryngol 117 1997 775 784
12. N. Lynam-Lennon, J.V. Reynolds, and G.P. Pidgeon et al. Alterations in DNA repair efficiency are involved in the radioresistance of esophageal adenocarcinoma Radiat Res 174 2010 703 711
13. K. Fukuda, C. Sakakura, and K. Miyagawa et al. Differential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiation Br J Cancer 91 2004 1543 1550
14. N.A. Franken, H.M. Rodermond, and J. Stap et al. Clonogenic assay of cells in vitro Nat Protoc 1 2006 2315 2319
15. A. Yang, N.S. Wilson, and A. Ashkenazi Proapoptotic DR4 and DR5 signaling in cancer cells: Toward clinical translation Curr Opin Cell Biol 22 2010 837 844
16. M.J. Worsham, J.K. Stephen, and K.M. Chen et al. Delineating an epigenetic continuum in head and neck cancer Cancer Lett 2012
17. C.A. Armstrong, G.D. Jones, and R. Anderson et al. DNMTs are required for delayed genome instability caused by radiation Epigenetics 7 2012 892 902
18. S.R. Wiley, K. Schooley, and P.J. Smolak et al. Identification and characterization of a new member of the TNF family that induces apoptosis Immunity 3 1995 673 682
19. R.M. Pitti, S.A. Marsters, and S. Ruppert et al. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family J Biol Chem 271 1996 12687 12690
20. R.S. Herbst, S.G. Eckhardt, and R. Kurzrock et al. Phase I dose-escalation study of recombinant human Apo2L/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancer J Clin Oncol 28 2010 2839 2846
21. J. Abdulghani, and W.S. El-Deiry TRAIL receptor signaling and therapeutics Expert Opin Ther Targets 14 2010 1091 1108
22. R. Jaenisch, and A. Bird Epigenetic regulation of gene expression: How the genome integrates intrinsic and environmental signals Nat Genet 33 Suppl. 2003 245 254
23. R.M. Glasspool, J.M. Teodoridis, and R. Brown Epigenetics as a mechanism driving polygenic clinical drug resistance Br J Cancer 94 2006 1087 1092
24. J. Loree, I. Koturbash, and K. Kutanzi et al. Radiation-induced molecular changes in rat mammary tissue: Possible implications for radiation-induced carcinogenesis Int J Radiat Biol 82 2006 805 815
25. C. Kuhmann, D. Weichenhan, and M. Rehli et al. DNA methylation changes in cells regrowing after fractioned ionizing radiation Radiother Oncol 101 2011 116 121
26. L. Luzhna, and O. Kovalchuk Modulation of DNA methylation levels sensitizes doxorubicin-resistant breast adenocarcinoma cells to radiation-induced apoptosis Biochem Biophys Res Commun 392 2010 113 117
27. S. Rodriguez-Nieto, and B. Zhivotovsky Role of alterations in the apoptotic machinery in sensitivity of cancer cells to treatment Curr Pharm Des 12 2006 4411 4425
28. H. Walczak, and P.H. Krammer The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems Exp Cell Res 256 2000 58 66
29. K. Schulze-Osthoff, D. Ferrari, and M. Los et al. Apoptosis signaling by death receptors Eur J Biochem 254 1998 439 459
30. E. Jabbour, J.P. Issa, and G. Garcia-Manero et al. Evolution of decitabine development: Accomplishments, ongoing investigations, and future strategies Cancer 112 2008 2341 2351
31. P.A. Jones, and S.B. Baylin The epigenomics of cancer Cell 128 2007 683 692
32. D. Matei, F. Fang, and C. Shen et al. Epigenetic resensitization to platinum in ovarian cancer Cancer Res 72 2012 2197 2205
33. S. Fu, W. Hu, and R. Iyer et al. Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer Cancer 117 2011 1661 1669